bruno villoutreix
Hôpital Robert Debré
Paris, France
Field Chief Editor
Frontiers in Drug Discovery
Type at least 3 characters
722 editors
Shape the future of research in your field
Join the board
Editors
Field Chief Editor
Specialty Chief Editors
abdel kareem azab
University of Texas Southwestern Medical Center
Dallas, United States
Specialty Chief Editor
Anti-Cancer Drugs
stefania galdiero
Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II
Naples, Italy
Specialty Chief Editor
Anti-Infective Agents
charles c hong
Michigan State University
East Lansing, United States
Specialty Chief Editor
Cardiovascular and Hematologic Drugs
josé l medina-franco
National Autonomous University of Mexico
México City, Mexico
Specialty Chief Editor
In silico Methods and Artificial Intelligence for Drug Discovery
robin polt
University of Arizona
Tucson, United States
Specialty Chief Editor
Neurological Drugs
tiago torres
University Hospital Center of Porto
Porto, Portugal
Specialty Chief Editor
Dermatologic Drugs
stephen geoffrey ward
University of Bath
Bath, United Kingdom
Specialty Chief Editor
Anti-inflammatory and Immunomodulating Agents
liang xu
University of Kansas
Lawrence, United States
Specialty Chief Editor
Technologies and Strategies to Enable Drug Discovery
Associate Editors
vishal acharya
Institute of Himalayan Bioresource Technology (CSIR)
Pālampur, India
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
arif nur muhammad ansori
Airlangga University
Surabaya, Indonesia
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
deepak balak
Leiden University Medical Center (LUMC)
Leiden, Netherlands
Associate Editor
Dermatologic Drugs
samuel d banister
Psylo
Sydney, Australia
Associate Editor
Neurological Drugs
rosa bellavita
University of Naples Federico II
Naples, Italy
Associate Editor
Anti-Infective Agents
hugues-olivier bertrand
Dassault Systèmes (France)
Vélizy-Villacoublay, France
Associate Editor
In silico Methods and Artificial Intelligence for Drug Discovery
jean bidlack
School of Medicine and Dentistry, University of Rochester
Rochester, United States
Associate Editor
Neurological Drugs